These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22825605)

  • 21. [Fludarabine-based increased-intensity conditioning regimen for allogeneic hematopoietic stem cell transplantation in acquired severe aplastic anemia].
    Sun C; Lin X; Huang Y; Song C; Tao Y; Tu S; Fang J; Chen T; Sun C; Wu B
    Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):221-4. PubMed ID: 24666488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cotransplantation of haploidentical hematopoietic stem cells and allogeneic bone marrow-derived mesenchymal stromal cells as a first-line treatment in very severe aplastic anemia patients with refractory infections.
    Yue C; Ding Y; Gao Y; Li L; Pang Y; Liu Z; Zhang H; Xiao Y; Jiang Z; Xiao H
    Eur J Haematol; 2018 Jun; 100(6):624-629. PubMed ID: 29532539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
    Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of bone marrow transplantation in leukaemia and aplastic anaemia.
    Storb R; Santos GW
    Clin Haematol; 1983 Oct; 12(3):721-37. PubMed ID: 6357579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with hepatitis-associated aplastic anemia.
    Mori T; Onishi Y; Ozawa Y; Kato C; Kai T; Kanda Y; Kurokawa M; Tanaka M; Ashida T; Sawayama Y; Fukuda T; Ichinohe T; Atsuta Y; Yamazaki H
    Int J Hematol; 2019 Jun; 109(6):711-717. PubMed ID: 30963471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alemtuzumab, fludarabine and melphalan as a conditioning therapy in severe aplastic anemia and hypoplastic myelodysplastic syndrome--single center experience.
    Rzepecki P; Sarosiek T; Szczylik C
    Jpn J Clin Oncol; 2006 Jan; 36(1):46-9. PubMed ID: 16423840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Syngeneic blood stem cell transplantation for infectious mononucleosis-related aplastic anaemia.
    Anderlini P; Riggs SA; Körbling M; Champlin R
    Br J Haematol; 1999 Jul; 106(1):159-61. PubMed ID: 10444179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aplastic anaemia: Current concepts in diagnosis and management.
    Furlong E; Carter T
    J Paediatr Child Health; 2020 Jul; 56(7):1023-1028. PubMed ID: 32619069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Aplastic anaemia].
    Hagestande S; Kvam AK; Lothe IMB; Gjelberg HK; Bruserud Ø; Tvedt THA
    Tidsskr Nor Laegeforen; 2020 Dec; 140(18):. PubMed ID: 33322881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unrelated donor search and unrelated donor transplantation in the adult aplastic anaemia patient aged 18-40 years without an HLA-identical sibling and failing immunosuppression.
    Bacigalupo A; Marsh JC
    Bone Marrow Transplant; 2013 Feb; 48(2):198-200. PubMed ID: 23178545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful engraftment of haploidentical bone marrow with post-transplantation cyclophosphamide in patients with aplastic anemia.
    Dang BN; De Oliveira S; Gray A; Bowles L; Moore TB
    Pediatr Transplant; 2020 Mar; 24(2):e13652. PubMed ID: 31944531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pilot trial of risk-adapted cyclophosphamide intensity based conditioning and HLA matched sibling and unrelated cord blood stem cell transplantation in newly diagnosed pediatric and adolescent recipients with acquired severe aplastic anemia.
    McGuinn C; Geyer MB; Jin Z; Garvin JH; Satwani P; Bradley MB; Bhatia M; George D; Duffy D; Morris E; van de Ven C; Schwartz J; Baxter-Lowe LA; Cairo MS
    Pediatr Blood Cancer; 2014 Jul; 61(7):1289-94. PubMed ID: 24623601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Special Education: Aplastic Anemia.
    Teramura M; Mizoguchi H
    Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allogeneic stem cell transplantation for children with acquired severe aplastic anaemia: a retrospective study by the Viva-Asia Blood and Marrow Transplantation Group.
    Chen J; Lee V; Luo CJ; Chiang AK; Hongeng S; Tan PL; Tan AM; Sanpakit K; Li CF; Lee AC; Chua HC; Okamoto Y
    Br J Haematol; 2013 Aug; 162(3):383-91. PubMed ID: 23735201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fludarabine-based reduced intensity regimen for matched related donor hematopoietic stem cell transplantation in acquired severe aplastic anemia.
    Ghanem KM; Kharfan-Dabaja MA; El-Solh H; Harris N; Kreidieh N; Nehme R; Muwakkit SA; Saab R; Bazarbachi A; Abboud MR
    Curr Res Transl Med; 2017 Sep; 65(3):115-119. PubMed ID: 28988743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allogeneic Hematopoietic Stem Cell Transplant for Severe Aplastic Anemia: Current State and Future Directions.
    Sun Q; Wu B; Zhu Z; Sun C; Xu J; Long H; Huang Y; Xu J; Song C
    Curr Stem Cell Res Ther; 2018; 13(5):350-355. PubMed ID: 28245775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hematopoietic stem cell transplantation in children and young adults with secondary myelodysplastic syndrome and acute myelogenous leukemia after aplastic anemia.
    Yoshimi A; Strahm B; Baumann I; Furlan I; Schwarz S; Teigler-Schlegel A; Walther JU; Schlegelberger B; Göhring G; Nöllke P; Führer M; Niemeyer CM
    Biol Blood Marrow Transplant; 2014 Mar; 20(3):425-9. PubMed ID: 24316460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonmyeloablative peripheral blood haploidentical stem cell transplantation for refractory severe aplastic anemia.
    Clay J; Kulasekararaj AG; Potter V; Grimaldi F; McLornan D; Raj K; de Lavallade H; Kenyon M; Pagliuca A; Mufti GJ; Marsh JC
    Biol Blood Marrow Transplant; 2014 Nov; 20(11):1711-6. PubMed ID: 25016195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Negative Impact of Cytomegalovirus Reactivation on Survival in Adult Patients with Aplastic Anemia after an Allogeneic Hematopoietic Stem Cell Transplantation: A Report from Transplantation-Related Complication and Adult Aplastic Anemia Working Groups of the Japan Society for Hematopoietic Cell Transplantation.
    Takenaka K; Onishi Y; Mori T; Hirakawa T; Tada Y; Uchida N; Kobayashi T; Kanda Y; Ozawa Y; Ota S; Iida H; Fukushima K; Kimua T; Fukuda T; Atsuta Y; Matsuto K; Yamazaki H; Nakasone H
    Transplant Cell Ther; 2021 Jan; 27(1):82.e1-82.e8. PubMed ID: 33039517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Revisiting acquired aplastic anaemia: current concepts in diagnosis and management.
    Clucas DB; Fox LC; Wood EM; Hong FS; Gibson J; Bajel A; Szer J; Blombery P; McQuilten ZK; Hiwase D; Firkin F; Cole-Sinclair MF;
    Intern Med J; 2019 Feb; 49(2):152-159. PubMed ID: 30324755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.